1. Pink Sheet
  2. >>Market Access

Health Care Industry Shaken After UnitedHealthcare CEO Is Killed Outside NYC Hotel

 
• By Leslie Small

The motive for the shocking murder of Brian Thompson in New York City was still unknown Wednesday afternoon.

United Healthcare CEO Brian Thompson was shot early 4 December in New York City. (Shutterstock)
Key Takeaways
  • The motive for UnitedHealthcare CEO Brian Thompson’s death remains unknown.
  • Thompson’s death shocked and saddened insurance industry stakeholders.
  • UnitedHealth Group CEO Andrew Witty abruptly ended the company’s Investor Day as news of Thompson’s death circulated.

UnitedHealthcare CEO Brian Thompson was shot and killed outside the New York Hilton Midtown hotel on 4 December, ahead of the annual investor day held by UnitedHealth Group, New York...

“We are deeply saddened and shocked at the passing of our dear friend and colleague Brian Thompson, the CEO of UnitedHealthcare,” UnitedHealth Group said in a statement posted on its...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

US FDA Will Help States Apply To Import Cheaper Drugs From Canada

 
• By Cathy Kelly

The FDA is not currently signaling that stringent rules for the process will be relaxed, but the agency's change in approach is notable.

Global Pandemic Deal Adopted As 124 Countries Say Yes; US Sits Out

 
• By Neena Brizmohun

Now that the landmark Pandemic Agreement has finally been adopted, work will start on drafting a pathogen access and benefit sharing system that will be voluntary for use by drug companies.

HHS Negotiating With Manufacturers On Most Favored Nation Drug Pricing

 
• By Cathy Kelly

MFN policy would would apply to all single source drugs in all insurance markets, according to HHS release. Secretary Robert F. Kennedy Jr. said the department is discussing the plan with drug sponsors.

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 
• By Francesca Bruce

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

More from PBMs

Is Optum Rx Payment Remodel To Favor Generics A Peace Offering For US FTC?

 
• By Urtė Fultinavičiūtė

Optum Rx, one of the largest PBMs in the US, declared it was the “first comprehensive, transparent pharmacy services company” after announcing several consumer-friendly changes.

Study Shows ‘Insurer-PBMs’ Dominate Medicare Part D, Steer Patients to Their Pharmacies

 
• By Jinghong Chen

An analysis of Medicare Part D and other data found that more than one-third of all pharmacy spending went through pharmacies owned by Cigna, CVS Health, Humana or UnitedHealth Group.

PBM Reform Legislation Do-Over Will Need Bipartisan Help Amid Partisan Budget Battle

 
• By Cathy Kelly

The leader of the House Energy and Commerce Health Subcommittee has a plan for passing pharmacy benefit manager reforms, but Democrats are skeptical.